- Presentations
- 7
- Markets
- 1
Briviact is a brand of Brivaracetam marketed by UCB, with 7 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Brivaracetam
- Brand owner
- UCB
- Registered in
- United States
- Strengths and forms
- 50 mg/5 mL injectable suspension, 10 mg/mL oral solution, 10 mg tablet, 100 mg tablet, 25 mg tablet, 50 mg tablet, 75 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Briviact 50 mg/5 mL injectable suspensionIntravenous | UCB | US FDA | Available on request |
| Briviact 10 mg/mL oral solutionOral | UCB | US FDA | Available on request |
| Briviact 10 mg tabletOral | UCB | US FDA | Available on request |
| Briviact 100 mg tabletOral | UCB | US FDA | Available on request |
| Briviact 25 mg tabletOral | UCB | US FDA | Available on request |
| Briviact 50 mg tabletOral | UCB | US FDA | Available on request |
| Briviact 75 mg tabletOral | UCB | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Briviact
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.